Cemex Analysts Slash Their Forecasts After Q3 Results

Benzinga

2024/10/29

CEMEX, S.A.B. de C.V. (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.

Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.

Cemex shares fell 8.7% to close at $5.46 on Monday.

These analysts made changes to their price targets on Cemex following earnings announcement.

JP Morgan analyst Adrian Huerta downgraded Cemex from Overweight to Neutral and lowered the price target from $7 to $6.
Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.

Considering buying CX stock? Here’s what analysts think:

Read More:

Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2479540201"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2479540201\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2479540201?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-29 21:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479540201","market":"us","top_or_hot":-1,"title":"Cemex Analysts Slash Their Forecasts After Q3 Results","media":"Benzinga","content":"<html><body><p><strong>CEMEX, S.A.B. de C.V.</strong> (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.</p>\n<p>Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.</p>\n<p>Cemex shares fell 8.7% to close at $5.46 on Monday.</p>\n<p>These analysts made changes to their price targets on Cemex following earnings announcement.</p>\n<ul>\n<li>JP Morgan analyst Adrian Huerta downgraded Cemex  from Overweight to Neutral and lowered the price target from $7 to $6.</li>\n<li>Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.</li>\n</ul>\n<p><strong>Considering buying CX stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"512\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298.png 1285w\" width=\"1024\"/></figure>\n<p><strong>Read More: </strong></p>\n<ul>\n<li><strong>Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone</strong></li>\n</ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cemex Analysts Slash Their Forecasts After Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCemex Analysts Slash Their Forecasts After Q3 Results\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2024-10-29 21:06</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong>CEMEX, S.A.B. de C.V.</strong> (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.</p>\n<p>Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.</p>\n<p>Cemex shares fell 8.7% to close at $5.46 on Monday.</p>\n<p>These analysts made changes to their price targets on Cemex following earnings announcement.</p>\n<ul>\n<li>JP Morgan analyst Adrian Huerta downgraded Cemex  from Overweight to Neutral and lowered the price target from $7 to $6.</li>\n<li>Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.</li>\n</ul>\n<p><strong>Considering buying CX stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"512\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298.png 1285w\" width=\"1024\"/></figure>\n<p><strong>Read More: </strong></p>\n<ul>\n<li><strong>Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone</strong></li>\n</ul></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4503","symbol_name":"景林資產持倉","start_time":0,"source_url":"https://www.benzinga.com/news/earnings/24/10/41598978/cemex-analysts-slash-their-forecasts-after-q3-results","article_id":"2479540201","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479540201","pubTimestamp":1730207199,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4503":"景林资产持仓","LU0080751232.USD":"富达环球多元动力基金A","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0215105999.USD":"SCHRODER ISF GLOBAL EQUITY \"A\" ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","CX":"西麦斯","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","LU0109392836.USD":"富兰克林科技股A","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","LU0079474960.USD":"联博美国增长基金A","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","BK4507":"流媒体概念","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","BK4548":"巴美列捷福持仓","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4561":"索罗斯持仓","LU0234570918.USD":"高盛全球核心股票组合Acc Close","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC"},"translate_title":"Cemex分析师在第三季度业绩公布后大幅下调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CX":0.9},"content_text":"CEMEX, S.A.B. de C.V. (NYSE:CX) reported worse-than-expected third-quarter financial results on Monday.\nCemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.\nCemex shares fell 8.7% to close at $5.46 on Monday.\nThese analysts made changes to their price targets on Cemex following earnings announcement.\n\nJP Morgan analyst Adrian Huerta downgraded Cemex  from Overweight to Neutral and lowered the price target from $7 to $6.\nBarclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.\n\nConsidering buying CX stock? Here’s what analysts think: \n\nRead More: \n\nDow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}